Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Reversible Cerebral Vasoconstriction Syndrome and Herpes Zoster Infection

NCT03509701 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT03509701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03509701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Reversible Cerebral Vasoconstriction Syndrome and Herpes Zoster Infection
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2018
Completion date
April 30, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

reversible cerebral vasoconstriction syndrome, varicella-zoster virus infection